Caxton Corp — 13F Holdings

2026 Q3  ·  13 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, CAXTON CORP maintained a portfolio of 13 distinct positions. The most significant new addition was NEW FORTRESS ENERGY INC, now representing 17.44% of the total fund value. They heavily accumulated shares in BLACKSTONE INC, increasing the position by 11.5%.
Position History hover any row below to update
Loading…
CAXTON CORP New York, NY Hedge Fund AUM $3M
PCA Score Concentration Risk
Risk ENB
Total Positions
13
Quarter
2026 Q3
Top Holding
SPCX (20.0%)
Top 10 Concentration
96.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13

CAXTON CORP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
SPCX
SPACE EXPLORATI...
ETF 20.04% 24.03% #1
Prev: #1
8.5
—
1,093 41.9%
P
S
3,699 $557,959
$164.95 -13.0%
$150.86 -4.9%
2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
NEW FORTRESS EN...
Preferred 17.44% — #2
Prev: #—
9.0
—
1,214 —
NEW
1,214 $485,612 — 13F Filing 2026-09-30 2026-11-16
BRK/B
BERKSHIRE HATHA...
Financial Services 15.00% 20.35% #3 1
Prev: #2
7.0
—
85 11.3%
P
S
839 $417,659 2012 Q4 13F Filing 2026-09-30 2026-11-16
TSLA
TESLA INC
Consumer Cyclical 10.57% — #4
Prev: #—
8.0
—
829 —
NEW
829 $294,263 2026 Q3 13F Filing 2026-09-30 2026-11-16
VOO
VANGUARD INDEX ...
ETF 9.51% 12.58% #5 1
Prev: #4
6.3
—
39 11.5%
P
S
378 $264,716 2026 Q2 13F Filing 2026-09-30 2026-11-16
GOOGL
ALPHABET INC
Communication Services 9.50% 13.32% #6 3
Prev: #3
5.8
—
78 11.3%
P
S
769 $264,562 2019 Q3 13F Filing 2026-09-30 2026-11-16
BX
BLACKSTONE INC
Financial Services 7.17% 10.16% #7 2
Prev: #5
4.9
—
183 11.5%
P
S
1,780 $199,534 2026 Q2 13F Filing 2026-09-30 2026-11-16
KYTX
KYVERNA THERAPE...
Healthcare 3.02% 5.94% #8 2
Prev: #6
2.2
—
no change no change
P
S
12,347 $83,958 2012 Q4 13F Filing 2026-09-30 2026-11-16
LXEO
LEXEO THERAPEUT...
Healthcare 2.06% 4.26% #9 2
Prev: #7
1.8
—
no change no change
P
S
16,962 $57,333 2012 Q4 13F Filing 2026-09-30 2026-11-16
IKT
INHIBIKASE THER...
Healthcare 2.05% 3.12% #10 1
Prev: #9
1.3
—
-678 -2.4%
P
S
27,775 $57,078 2012 Q4 13F Filing 2026-09-30 2026-11-16
XFOR
X4 PHARMACEUTIC...
Healthcare 1.41% 3.92% #11 3
Prev: #8
1.1
—
-2,023 -13.0%
P
S
13,534 $39,248 2012 Q4 13F Filing 2026-09-30 2026-11-16
SABS
SAB BIOTHERAPEU...
Healthcare 1.18% — #12
Prev: #—
4.0
—
10,372 —
NEW
10,372 $32,878 2012 Q4 13F Filing 2026-09-30 2026-11-16
ALXO
ALX ONCOLOGY HL...
Healthcare 1.05% 2.34% #13 3
Prev: #10
1.4
—
no change no change
P
S
20,946 $29,115 2026 Q1 13F Filing 2026-09-30 2026-11-16
Showing 1-13 of 13 holdings

Unlock Full CAXTON CORP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →